# Product Requirements Document (PRD)
## Closed-Loop Diabetes Management System

**Document Version:** 1.0
**Date:** 2025-11-23
**Product Name:** DiabetesCare Loop (Working Title)
**Product Type:** Medical Device Software - Closed-Loop Insulin Delivery System

---

## Executive Summary

DiabetesCare Loop is an automated closed-loop insulin delivery system for Type 1 Diabetes management. The system integrates continuous glucose monitoring (CGM) data with insulin pump control, using machine learning algorithms to predict glucose trends and automatically adjust insulin delivery, minimizing user intervention while maintaining safe glucose levels.

---

## 1. Product Vision & Goals

### Vision
Empower Type 1 Diabetes patients with a fully automated, intelligent insulin management system that reduces the burden of constant monitoring and manual insulin dosing while improving glycemic control and quality of life.

### Primary Goals
1. Achieve Time in Range (TIR) of 70%+ for users (glucose 70-180 mg/dL)
2. Reduce hypoglycemic events by 50% compared to manual management
3. Minimize user intervention to <5 interactions per day
4. Provide real-time glucose predictions with 95% accuracy within 30 minutes
5. Achieve FDA Class III medical device clearance (or equivalent regulatory approval)

### Success Metrics
- **Clinical Metrics:**
  - Mean glucose level: 140-160 mg/dL
  - Glucose variability (CV): <36%
  - Time below range (<70 mg/dL): <4%
  - Time above range (>180 mg/dL): <25%
  - HbA1c reduction: 0.5-1.0% improvement

- **User Experience Metrics:**
  - User satisfaction score: >4.5/5
  - Daily active users: >90% retention
  - Average time to onboarding: <30 minutes
  - System uptime: 99.9%

- **Safety Metrics:**
  - Zero severe hypoglycemic events attributed to system
  - Alert response time: <30 seconds
  - Fail-safe activation: 100% reliability

---

## 2. Target Users

### Primary User Persona
**Name:** Sarah, 28-year-old with Type 1 Diabetes
**Experience:** 10 years since diagnosis
**Tech-savviness:** High
**Current Setup:** CGM + insulin pump (manual control)
**Pain Points:**
- Constant monitoring and calculations
- Fear of hypoglycemia during sleep
- Difficulty managing exercise and meals
- Burnout from diabetes management burden

### Secondary Personas
1. **Caregivers/Parents:** Managing children with T1D
2. **Elderly Users:** Need simpler interface and clear alerts
3. **Newly Diagnosed:** Learning diabetes management
4. **Athletes:** Need precise control during physical activity

### User Needs
- Automated insulin delivery with minimal intervention
- Reliable glucose predictions
- Clear, actionable alerts
- Remote monitoring capabilities (caregivers)
- Historical data and insights
- Integration with existing medical records
- Educational resources

---

## 3. Core Features & Requirements

### 3.1 Must-Have Features (MVP)

#### A. Continuous Glucose Monitoring Integration
- **REQ-CGM-001:** System must connect to Dexcom G6/G7 CGM devices via Bluetooth
- **REQ-CGM-002:** Glucose readings must be updated every 1-5 minutes
- **REQ-CGM-003:** Display current glucose value, trend arrow, and rate of change
- **REQ-CGM-004:** Store at least 90 days of CGM data locally
- **REQ-CGM-005:** Handle CGM sensor signal loss gracefully with user alerts

#### B. Insulin Pump Integration
- **REQ-PUMP-001:** Connect to compatible insulin pumps via Bluetooth
- **REQ-PUMP-002:** Support for basal rate adjustments (0.025-30 U/hr)
- **REQ-PUMP-003:** Support for bolus delivery (0.05-25 U increments)
- **REQ-PUMP-004:** Real-time insulin-on-board (IOB) calculation
- **REQ-PUMP-005:** Automatic pump status monitoring (reservoir level, battery, occlusions)
- **REQ-PUMP-006:** Emergency stop functionality with <1 second response time

#### C. Automated Insulin Delivery (Closed-Loop)
- **REQ-AID-001:** Automatic basal rate adjustments every 5 minutes based on glucose trends
- **REQ-AID-002:** Predictive low glucose suspend (PLGS) when hypoglycemia predicted
- **REQ-AID-003:** Automatic correction doses when glucose trending high
- **REQ-AID-004:** Configurable target glucose range (e.g., 100-120 mg/dL)
- **REQ-AID-005:** Manual override capability (user can always take control)
- **REQ-AID-006:** Activity modes (exercise, sleep, illness) with different algorithms
- **REQ-AID-007:** Maximum insulin delivery limits (safety constraints)

#### D. Glucose Prediction & ML Algorithms
- **REQ-ML-001:** 30-minute glucose prediction with confidence intervals
- **REQ-ML-002:** 60-minute glucose prediction for trend analysis
- **REQ-ML-003:** Meal absorption prediction and insulin timing optimization
- **REQ-ML-004:** Exercise impact prediction based on activity data
- **REQ-ML-005:** Personalized algorithm adaptation based on user data
- **REQ-ML-006:** Prediction accuracy reporting to user

#### E. User Interface (Mobile Apps)
- **REQ-UI-001:** Native iOS app (iOS 15+)
- **REQ-UI-002:** Native Android app (Android 10+)
- **REQ-UI-003:** Dashboard with glucose graph, predictions, and system status
- **REQ-UI-004:** Carbohydrate logging with meal database
- **REQ-UI-005:** Exercise/activity logging
- **REQ-UI-006:** Alert and notification management
- **REQ-UI-007:** Settings and configuration panel
- **REQ-UI-008:** Historical data visualization (daily, weekly, monthly)
- **REQ-UI-009:** Offline mode with local data storage

#### F. Alerts & Notifications
- **REQ-ALERT-001:** High glucose alerts (customizable threshold)
- **REQ-ALERT-002:** Low glucose alerts with urgent notifications
- **REQ-ALERT-003:** Predicted hypoglycemia warnings (15-30 min advance)
- **REQ-ALERT-004:** Device connectivity loss alerts
- **REQ-ALERT-005:** Insulin delivery failure alerts
- **REQ-ALERT-006:** Low reservoir/battery warnings
- **REQ-ALERT-007:** Alert escalation (sound, vibration, repeated notifications)

#### G. Safety Systems
- **REQ-SAFE-001:** Multiple layers of insulin delivery limits
- **REQ-SAFE-002:** Fail-safe mode reverts to pre-programmed basal rates
- **REQ-SAFE-003:** Watchdog timers for all critical functions
- **REQ-SAFE-004:** Data validation and sanity checks
- **REQ-SAFE-005:** User confirmation for large bolus doses (>5U)
- **REQ-SAFE-006:** System health monitoring and auto-diagnostics

#### H. Data Management & Backend
- **REQ-DATA-001:** HIPAA-compliant cloud storage
- **REQ-DATA-002:** End-to-end encryption for all data transmission
- **REQ-DATA-003:** Automatic backup and sync
- **REQ-DATA-004:** Data export in standard formats (CSV, PDF reports)
- **REQ-DATA-005:** API for integration with healthcare providers

### 3.2 Should-Have Features (Post-MVP)

- **Remote monitoring:** Caregiver/family access to glucose data
- **Smart integrations:** Apple Health, Google Fit, Fitbit
- **Advanced meal logging:** Photo-based carb estimation using ML
- **Voice commands:** Hands-free carb logging and status checks
- **Smartwatch app:** Quick glance glucose monitoring
- **Insulin sensitivity tracking:** Automatic ISF/ICR adjustments
- **Pregnancy mode:** Tighter glucose control for pregnant users
- **Travel mode:** Timezone adjustment assistance

### 3.3 Nice-to-Have Features (Future)

- **Multi-hormone delivery:** Glucagon integration for better control
- **Social features:** Community support and data comparison
- **Telemedicine integration:** Direct connection with endocrinologists
- **AI coach:** Personalized recommendations and education
- **Predictive maintenance:** Device failure prediction
- **Genetic/metabolic profiling:** Personalized algorithm tuning

---

## 4. Device Compatibility

### CGM Devices (Initial Support)
- Dexcom G6
- Dexcom G7
- (Future: Freestyle Libre 3, Guardian 4)

### Insulin Pumps (Initial Support)
- Omnipod DASH
- Omnipod 5
- Tandem t:slim X2
- (Future: Medtronic 780G, DANA-i)

### Mobile Devices
- iOS: iPhone 8 and newer (iOS 15+)
- Android: Android 10+ with Bluetooth 5.0

---

## 5. Regulatory & Compliance Requirements

### Medical Device Classification
- **FDA:** Class III medical device (Premarket Approval required)
- **EU:** Class IIb medical device (MDR compliance)
- **Standards Compliance:**
  - IEC 62304 (Medical device software lifecycle)
  - ISO 14971 (Risk management)
  - ISO 13485 (Quality management)
  - IEC 60601-1 (Medical electrical equipment safety)

### Data Privacy & Security
- **HIPAA compliance** (US)
- **GDPR compliance** (EU)
- **SOC 2 Type II certification**
- **Penetration testing** and security audits

### Clinical Validation
- Clinical trials demonstrating safety and efficacy
- Minimum 6-month pivotal study with 200+ participants
- Real-world evidence collection post-launch

---

## 6. Technical Constraints

### Performance Requirements
- **REQ-PERF-001:** Algorithm decision cycle: <30 seconds
- **REQ-PERF-002:** Alert latency: <5 seconds from detection
- **REQ-PERF-003:** App launch time: <3 seconds
- **REQ-PERF-004:** Glucose data sync: <10 seconds
- **REQ-PERF-005:** Battery life: 24+ hours on mobile device

### Reliability Requirements
- **REQ-REL-001:** System uptime: 99.9%
- **REQ-REL-002:** Data loss: <0.01% of readings
- **REQ-REL-003:** Bluetooth connection reliability: >98%
- **REQ-REL-004:** Graceful degradation when components fail

### Scalability Requirements
- Support for 100,000+ concurrent users at launch
- Backend capacity for 1M+ users within 2 years
- Data storage: 5-year retention minimum

---

## 7. User Experience Requirements

### Onboarding
- Initial setup: <30 minutes
- Device pairing: <5 minutes per device
- Profile configuration: guided wizard
- Safety training: mandatory completion
- Practice mode: simulated closed-loop before activation

### Daily Interaction
- Minimal required interactions: <5 per day
- Meal logging: <30 seconds
- Status check: <5 seconds
- Alert acknowledgment: <2 taps

### Accessibility
- WCAG 2.1 AA compliance
- Screen reader support
- Large text options
- Color-blind friendly design
- Multi-language support (initially: English, Spanish)

---

## 8. Business Requirements

### Monetization Model
- **Option A:** Subscription-based ($50-100/month)
- **Option B:** One-time license + hardware bundle
- **Option C:** Insurance reimbursement model

### Support Requirements
- 24/7 technical support (phone, chat, email)
- Average response time: <30 minutes for critical issues
- Dedicated diabetes educator support
- Online knowledge base and tutorials

### Integration Requirements
- Insurance verification API
- Pharmacy benefit managers (PBM) integration
- Electronic health records (EHR) integration (HL7 FHIR)

---

## 9. Out of Scope (Version 1.0)

- Type 2 diabetes management
- Non-pump insulin delivery (MDI users)
- Pediatric users (<6 years old)
- Dual-hormone systems (insulin + glucagon)
- Fully implantable devices
- Direct glucose sensing (non-CGM)

---

## 10. Risks & Mitigations

### Critical Risks

| Risk | Impact | Mitigation |
|------|--------|------------|
| Severe hypoglycemia from over-delivery | Life-threatening | Multiple safety limits, conservative algorithms, extensive testing |
| Device connectivity failure | Loss of closed-loop | Automatic fail-safe mode, user alerts, redundant connections |
| Algorithm prediction errors | Poor glycemic control | Confidence intervals, human-in-the-loop override, continuous validation |
| Regulatory non-approval | Cannot launch | Early FDA engagement, clinical trial excellence, regulatory consultants |
| Data breach | HIPAA violation, user harm | Military-grade encryption, security audits, penetration testing |
| Battery drain | System unavailability | Optimized code, background processing limits, low-power modes |

---

## 11. Dependencies

### External Dependencies
- CGM manufacturer API access and certification
- Insulin pump manufacturer API access and certification
- Cloud service provider (AWS/Azure/GCP)
- Clinical research organization for trials
- Regulatory consultants
- Insurance partnerships

### Internal Dependencies
- ML/AI team for algorithm development
- Clinical advisory board
- Quality assurance and regulatory affairs team
- Mobile development team (iOS + Android)
- Backend engineering team
- DevOps and infrastructure team

---

## 12. Acceptance Criteria

### Launch Readiness Checklist
- [ ] FDA Premarket Approval obtained
- [ ] Clinical trial results demonstrate safety and efficacy
- [ ] All must-have features implemented and tested
- [ ] Security audit passed with zero critical vulnerabilities
- [ ] 10,000+ hours of closed-loop testing completed
- [ ] 24/7 support team trained and ready
- [ ] Marketing and user education materials complete
- [ ] Insurance reimbursement codes secured
- [ ] Manufacturing/distribution partnerships established
- [ ] Post-market surveillance system in place

### Success Criteria (6 months post-launch)
- 5,000+ active users
- Average TIR: >70%
- Zero severe adverse events attributed to system
- User satisfaction: >4.5/5
- System uptime: >99.9%
- Regulatory compliance: 100%

---

## 13. Glossary

- **TIR (Time in Range):** Percentage of time glucose is within target range
- **IOB (Insulin on Board):** Active insulin still affecting glucose
- **CGM (Continuous Glucose Monitor):** Device that measures glucose every 1-5 min
- **Basal:** Background insulin delivery rate
- **Bolus:** Insulin dose for meals or corrections
- **ISF (Insulin Sensitivity Factor):** How much 1U of insulin lowers glucose
- **ICR (Insulin-to-Carb Ratio):** How much insulin needed per gram of carbs
- **PLGS (Predictive Low Glucose Suspend):** Automatic insulin stop before hypoglycemia
- **HbA1c:** 3-month average glucose level indicator

---

## Appendix A: Regulatory Pathway Timeline

1. **Pre-Submission (Month 1-3):** FDA Q-Sub meeting
2. **Clinical Trial Design (Month 4-6):** Protocol development and approval
3. **Feasibility Study (Month 7-12):** 50 participants, 3 months
4. **Pivotal Trial (Month 13-24):** 200+ participants, 6 months
5. **PMA Submission (Month 25-27):** Complete application package
6. **FDA Review (Month 28-39):** Interactive review process
7. **Approval & Launch (Month 40+):** Commercial release

---

**Document Approval:**
- Product Manager: _________________
- Chief Medical Officer: _________________
- Regulatory Affairs: _________________
- Engineering Lead: _________________

**Change Log:**
| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-11-23 | Initial | First draft |
